
An epilepsy study linked abnormal immature astroglia with poorer reasoning scores. Learn how it was conducted and why the finding remains preliminary.

On October 19, 2026, USC researchers published a study in Frontiers in Cellular Neuroscience linking abnormal immature astroglia in the hippocampus with poorer fluid-intelligence performance in people with mesial temporal lobe epilepsy (MTLE).
According to USC Stem Cell, researchers compared cognitive-test results with hippocampal tissue from 29 patients who underwent surgery for severe seizures that had not responded to drugs. Patients completed the tests before surgery. Researchers then counted immature astroglia in selected areas of the removed tissue.
Astroglia are brain-support cells. This study focused on cells described as abnormal and immature. USC reported that older patients tended to have more of these cells and that greater cell abundance was associated with poorer performance on tests of fluid intelligence.
The finding brings together two kinds of information: how patients performed on cognitive tests and what researchers observed in their brain tissue. The connection between those measurements is the central result of the study.
Fluid intelligence means reasoning through new problems. According to the study summary reported by Neuroscience News, researchers assessed it using Raven’s Progressive Matrices. The wider testing covered memory, attention, language and fine motor coordination.
That distinction helps keep the headline precise. The central cell-related finding concerned reasoning through unfamiliar problems. It should not be widened into a claim about every aspect of a person's thinking or treated as a complete description of their abilities.
The Neuroscience News study summary reports separate participant counts for different questions:
For the headline result, the most relevant count is 19 because that analysis examined the cell-cognition relationship. Using the largest participant count to describe every finding would give readers the wrong impression of how much evidence supports that particular link.
The summary also reports age-related declines in fluid intelligence, visuospatial reconstruction and memory. Those broader cognitive patterns are separate from the more specific analysis connecting immature astroglia with reasoning performance.
USC explains that studying individual brain cells directly in living people is difficult. Common non-invasive tools such as MRI and EEG do not usually provide enough resolution to examine individual cells. Tissue obtained during epilepsy surgery offered another way to investigate the question.
The researchers could connect testing completed before surgery with cell counts made afterward. This makes the work a human-tissue study tied to measured cognitive performance. The opportunity came from patients receiving surgery for epilepsy rather than from a project designed to sample the wider older population.
For adults over 60, the immediate value is a clearer research question: how might changes in brain-support cells relate to flexible reasoning? The study gives researchers a specific cell population to investigate rather than referring broadly to “brain aging.”
For a clinician discussing the paper with a patient, the useful starting point is what the researchers actually measured. A question about solving new problems is different from a question about remembering information. Keeping the tested ability in view makes a conversation about the finding more accurate.
For anyone concerned about personal changes in memory or reasoning, a qualified health professional is the right place for an individual assessment. The useful discussion is about the person's experience and circumstances rather than an attempt to interpret a cellular finding from a headline.
Questions about everyday habits also need their own evidence. FitBrainLab's coverage of how walking studies assess brain-health links and how sleep research relates to memory addresses different research questions. Those topics deserve to be judged on their own findings rather than connected to astroglia by assumption.
The first boundary is causation. USC says more research is needed to determine whether these cells contribute directly to cognitive decline. Finding more cells alongside poorer reasoning scores does not establish that the cells caused the difference or that changing them would preserve reasoning.
The second boundary concerns who was studied. These were patients with MTLE who required surgery for severe drug-resistant seizures. The central cell-cognition comparison was also small. The findings should not be treated as established for healthy older adults or used to predict an individual reader's cognitive future.
The third boundary is actionability. According to USC's account, the study does not identify a proven treatment, lifestyle intervention or modifiable personal risk factor. It supplies a possible direction for research rather than a tested way for readers to protect their cognitive health.
Some of the researchers' language looks further ahead. Co-corresponding author Michael Bonaguidi said the work “could someday help us slow down or potentially even reverse age-related declines in our ability to solve new problems.” That statement describes a research aspiration. It is not a result demonstrated by this study.
USC says researchers are investigating molecular differences in immature astroglia that could inform future drug targets. It also identifies neuromodulation as another possible research direction. Both belong to the next stage of investigation rather than to a treatment recommendation arising from the current finding.
The practical response is straightforward: this paper alone is not a reason to change health routines or seek an unproven astroglia treatment. Ordinary lapses should not be interpreted as evidence of this cellular process. The research question belongs in the laboratory while personal cognitive concerns belong in qualified care.
The study's value lies in connecting a specific cell finding with a clearly named cognitive skill in human tissue. That gives future work a focused question: what role do abnormal immature astroglia play in reasoning as people age? Answering it would help clarify what the observed relationship means.
For the long-term study of cognitive health, progress includes making questions more precise. “Brain aging” covers many abilities and biological processes. Research that links a defined cell population with a defined cognitive outcome can help move the discussion toward clearer explanations. That is why this early finding deserves attention without being turned into a personal health forecast.
Cell-level explanations of aging offer detail without settling which daily habits support cognition, a distinction FitBrainLab keeps clear in its research-led reporting. By translating evidence on memory, lifestyle and brain aging for adults 60+, it helps readers work through uncertainty about everyday choices without turning a laboratory finding into a personal health promise.
Follow FitBrainLab for research-led insights on memory, focus, brain aging, nutrition and mental fitness after 60. Stay connected for new articles, practical guidance and ideas for a sharper, more engaged life.



Build habits that support memory, focus and a curious, connected life.
Read the Blog